Cancer remains a major cause of death globally. Given its relapsing and fatal features,
curing cancer seems to be something hardly possible for the majority of patients. In view of …

“Those who cannot remember the past are condemned to repeat it.” George Santayana
1905 “If men could learn from history, what lessons it might teach us! But passion and party …

PURPOSE Since the 1980s, both the incidence of differentiated thyroid cancer (DTC) and
use of radioactive iodine (RAI) treatment increased markedly. RAI has been associated with …

Importance Radioactive iodine (RAI) has been used extensively to treat hyperthyroidism
since the 1940s. Although widely considered a safe and effective therapy, RAI has been …

Mutations of subunits of the SWI/SNF chromatin remodeling complexes occur commonly in
cancers of different lineages, including advanced thyroid cancers. Here we show that thyroid …

Radiopharmaceutical therapies are gaining increasing prominence as they improve survival
in patients with common diseases such as metastatic prostate cancer (1, 2). However …

Purpose: The determinants of response or resistance to radioiodine (RAI) are unknown. We
aimed to identify genomic and transcriptomic factors associated with structural responses to …

Importance Whether radioactive iodine (RAI) therapy for hyperthyroidism can increase
cancer risk remains a controversial issue in medicine and public health. Objectives To …

Background We aimed to investigate whether the risk of second primary malignancy (SPM)
in patients with thyroid cancer (TC) receiving radioactive iodine (RAI) therapy rises in a …

Background: The potential risk of subsequent malignant neoplasms (SMNs) after radioactive
iodine (RAI) treatment of thyroid cancer (TC) is an important concern. Methods: A systematic …